| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 5 |
| 1 | ADALIMUMAB-AATY | 5 |
| 2 | ADALIMUMAB-ADAZ | 5 |
| 3 | ADALIMUMAB-FKJP | 5 |
| 4 | RITUXIMAB | 5 |
| 5 | ASPIRIN | 3 |
| 6 | ASPIRIN 325 MG | 3 |
| 7 | ASPIRIN 81 MG | 3 |
| 8 | CYCLOPHOSPHAMIDE | 3 |
| 9 | CYCLOPHOSPHAMIDE FOR INJECTION | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ATACICEPT | 1 | 0.1250 |
| 1 | OLUTASIDENIB | 1 | 0.0035 |
| 2 | MOSUNETUZUMAB | 1 | 0.0009 |
| 3 | RILONACEPT | 1 | 0.0009 |
| 4 | BRODALUMAB | 1 | 0.0005 |
| 5 | BARICITINIB | 1 | 0.0003 |
| 6 | BELATACEPT | 1 | 0.0002 |
| 7 | ADALIMUMAB-FKJP | 5 | 0.0001 |
| 8 | ADALIMUMAB-AATY | 5 | 0.0001 |
| 9 | CANAKINUMAB | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD19-directed Cytolytic Antibody [EPC] | 1 | 0.0012 |
| 1 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 2 | Selective T Cell Costimulation Blocker [EPC] | 1 | 0.0002 |
| 3 | Vasopressin V2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 4 | Interleukin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 5 | Interleukin-17A Antagonist [EPC] | 2 | 0.0001 |
| 6 | Prostacyclin Receptor Agonist [EPC] | 1 | 0.0000 |
| 7 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Penem Antibacterial [EPC] | 1 | 0.0000 |
| 9 | Muscle Relaxant [EPC] | 1 | 0.0000 |